Clinical TrialsAlterity Pushes ATH434 Toward Phase 3 With New MSA Disease-Modifying Signal... Alterity Pushes ATH434 Toward Phase 3 With New MSA Disease-Modifying Signal... Read Post »
Clinical TrialsBioMarin Sees Biomarker Win Fade Against Clinical Reality in ENERGY 3 Trial BioMarin Sees Biomarker Win Fade Against Clinical Reality in ENERGY 3 Trial Read Post »
Clinical TrialsSanofi Reports Positive Phase 2 Results for Efdoralprin Alfa in AATD Sanofi Reports Positive Phase 2 Results for Efdoralprin Alfa in AATD Read Post »
New Drug ApprovalJapan Expands GSK’s Arexvy Approval to At-Risk Adults Aged 18–49 Japan Expands GSK’s Arexvy Approval to At-Risk Adults Aged 18–49 Read Post »
Clinical TrialsMerck’s Sac-TMT Shows Survival Benefit in Advanced Endometrial Cancer Merck’s Sac-TMT Shows Survival Benefit in Advanced Endometrial Cancer Read Post »
New Drug ApprovalBoehringer Ingelheim Secures Japan Approval for JASCAYD in Pulmonary Fibros... Boehringer Ingelheim Secures Japan Approval for JASCAYD in Pulmonary Fibros... Read Post »
ResearchTeva Highlights the Unseen Psychological Toll of Tardive Dyskinesia Teva Highlights the Unseen Psychological Toll of Tardive Dyskinesia Read Post »
New Drug ApprovalFDA Approves AstraZeneca’s Baxfendy, an Aldosterone-Targeting Therapy... FDA Approves AstraZeneca’s Baxfendy, an Aldosterone-Targeting Therapy... Read Post »
Clinical TrialsRalinepag Improved Outcomes in Phase III Pulmonary Hypertension Study Ralinepag Improved Outcomes in Phase III Pulmonary Hypertension Study Read Post »
Clinical TrialsNovartis Shows Improved PSA Responses With Pluvicto in Phase III mHSPC Tria... Novartis Shows Improved PSA Responses With Pluvicto in Phase III mHSPC Tria... Read Post »
Clinical TrialsFDA Clears United Therapeutics’ UHeart Trial in End-Stage Heart Failure FDA Clears United Therapeutics’ UHeart Trial in End-Stage Heart Failure Read Post »
ResearchWhat Is Hantavirus? Understanding Its Spread, Structure, Symptoms, and Risk... What Is Hantavirus? Understanding Its Spread, Structure, Symptoms, and Risk... Read Post »
ResearchNIH-Funded Study Finds Testosterone May Suppress Glioblastoma Growth in Men NIH-Funded Study Finds Testosterone May Suppress Glioblastoma Growth in Men Read Post »
ResearchNIH-Funded Nature Study Finds Orforglipron Suppresses Pleasure-Driven Eatin... NIH-Funded Nature Study Finds Orforglipron Suppresses Pleasure-Driven Eatin... Read Post »
Clinical TrialsRegeneron Continues Melanoma Development After Phase 3 Trial Miss Regeneron Continues Melanoma Development After Phase 3 Trial Miss Read Post »
New Drug ApprovalFDA Approves Tecentriq as First ctDNA-Guided Therapy for Bladder Cancer FDA Approves Tecentriq as First ctDNA-Guided Therapy for Bladder Cancer Read Post »
New Drug ApprovalMHRA Approves Vyjuvek for Dystrophic Epidermolysis Bullosa MHRA Approves Vyjuvek for Dystrophic Epidermolysis Bullosa Read Post »
New Drug ApprovalFDA Approves Enhertu After Positive DESTINY-Breast Phase III Results FDA Approves Enhertu After Positive DESTINY-Breast Phase III Results Read Post »
Clinical TrialsXPro™ Shows Cognitive and Biomarker Benefits in Phase 2 Alzheimer’s Tri... XPro™ Shows Cognitive and Biomarker Benefits in Phase 2 Alzheimer’s Tri... Read Post »
Clinical TrialsPalvella Reports Phase 2 Data Supporting QTORIN in Rare Vascular Disorder Palvella Reports Phase 2 Data Supporting QTORIN in Rare Vascular Disorder Read Post »
Clinical TrialsAstraZeneca’s VOLGA Trial Shows Perioperative Imfinzi Plus Enfortumab Ved... AstraZeneca’s VOLGA Trial Shows Perioperative Imfinzi Plus Enfortumab Ved... Read Post »
Clinical TrialsBiogen’s Diranersen Falls Short on Primary Goal Yet Signals a Breakthroug... Biogen’s Diranersen Falls Short on Primary Goal Yet Signals a Breakthroug... Read Post »
Clinical TrialsEyePoint Confirms Favorable Safety Profile for DURAVYU in Phase 3 Wet AMD T... EyePoint Confirms Favorable Safety Profile for DURAVYU in Phase 3 Wet AMD T... Read Post »
Clinical TrialsREGENXBIO Delivers Positive Results for Duchenne Therapy RGX-202 REGENXBIO Delivers Positive Results for Duchenne Therapy RGX-202 Read Post »
Clinical TrialsShionogi Builds a New COVID-19 Defense Line With Positive Phase 3 Ensitrelv... Shionogi Builds a New COVID-19 Defense Line With Positive Phase 3 Ensitrelv... Read Post »
New Drug ApprovalTaiho’s INQOVI With Venetoclax Approved for Patients Unable to Receive In... Taiho’s INQOVI With Venetoclax Approved for Patients Unable to Receive In... Read Post »
New Drug ApprovalBeOne Gains FDA Accelerated Approval for BEQALZI in MCL BeOne Gains FDA Accelerated Approval for BEQALZI in MCL Read Post »
New Drug ApprovalEuropean Commission Approves Pfizer’s HYMPAVZI for Haemophilia Patients European Commission Approves Pfizer’s HYMPAVZI for Haemophilia Patients Read Post »
Clinical TrialsEncoded Presents Positive POLARIS Data for ETX101 in Dravet Syndrome Encoded Presents Positive POLARIS Data for ETX101 in Dravet Syndrome Read Post »
Clinical TrialsKura Oncology and Kyowa Kirin Report Updated Frontline Data from KOMET-007 ... Kura Oncology and Kyowa Kirin Report Updated Frontline Data from KOMET-007 ... Read Post »
Clinical TrialsNovo Nordisk Reports Up to 21.6% Weight Loss with Oral Wegovy in OASIS 4 An... Novo Nordisk Reports Up to 21.6% Weight Loss with Oral Wegovy in OASIS 4 An... Read Post »
Clinical TrialsAstellas’s IZERVAY Reduced Risk of Driving Eligibility Loss in Geogra... Astellas’s IZERVAY Reduced Risk of Driving Eligibility Loss in Geogra... Read Post »
Clinical TrialsLilly Reports Long-Term Weight Maintenance Data for Foundayo and Zepbound a... Lilly Reports Long-Term Weight Maintenance Data for Foundayo and Zepbound a... Read Post »
Clinical TrialsAlnylam Reports Consistent HELIOS-B Benefits of Vutrisiran in ATTR-CM Alnylam Reports Consistent HELIOS-B Benefits of Vutrisiran in ATTR-CM Read Post »
Clinical TrialsNovo Nordisk Presents New Wegovy Menopause Data at ECO 2026 Novo Nordisk Presents New Wegovy Menopause Data at ECO 2026 Read Post »
Clinical TrialsBridgeBio Files FDA NDA for Encaleret in Rare Calcium Disorder BridgeBio Files FDA NDA for Encaleret in Rare Calcium Disorder Read Post »
Clinical TrialsAstraZeneca Pushes Eneboparatide Forefront in Hypoparathyroidism with CALYP... AstraZeneca Pushes Eneboparatide Forefront in Hypoparathyroidism with CALYP... Read Post »
Clinical TrialsNovo Nordisk Shows 27.7% Weight Loss With Higher-Dose Wegovy in STEP UP Tri... Novo Nordisk Shows 27.7% Weight Loss With Higher-Dose Wegovy in STEP UP Tri... Read Post »
Clinical TrialsCytokinetics Unveils New MYQORZO Clinical and Real-World Data at ESC 2026 Cytokinetics Unveils New MYQORZO Clinical and Real-World Data at ESC 2026 Read Post »
Drugs Safety AlertMHRA Reinforces Safety Advice for Men Taking Finasteride and Dutasteride MHRA Reinforces Safety Advice for Men Taking Finasteride and Dutasteride Read Post »
ResearchFibroBiologics Advancing Development of a Fibroblast Treatment for Hantavir... FibroBiologics Advancing Development of a Fibroblast Treatment for Hantavir... Read Post »
Clinical TrialsBridgeBio Presents New ATTRibute-CM Data Supporting Acoramidis at Heart Fai... BridgeBio Presents New ATTRibute-CM Data Supporting Acoramidis at Heart Fai... Read Post »
Clinical TrialsViiV Advances Paediatric HIV Care with Dovato Submissions to EMA and FDA ViiV Advances Paediatric HIV Care with Dovato Submissions to EMA and FDA Read Post »
New Drug ApprovalHenlius Secures EU Approval for Serplulimab in Lung and Esophageal Cancers Henlius Secures EU Approval for Serplulimab in Lung and Esophageal Cancers Read Post »
New Drug ApprovalFDA Approves Bizengri for Rare NRG1-Positive Cholangiocarcinoma FDA Approves Bizengri for Rare NRG1-Positive Cholangiocarcinoma Read Post »
New Drug ApprovalFDA Approves VYVGART for All Adult gMG Antibody Subtypes FDA Approves VYVGART for All Adult gMG Antibody Subtypes Read Post »
New Drug ApprovalGenentech Wins FDA Approval for Ocrevus in Pediatric Multiple Sclerosis Genentech Wins FDA Approval for Ocrevus in Pediatric Multiple Sclerosis Read Post »
Clinical TrialsAtsena Presents Encouraging Long-Term Data in XLRS and LCA1 Atsena Presents Encouraging Long-Term Data in XLRS and LCA1 Read Post »
New Drug ApprovalEU Clears BMS’s Sotyktu for Adults With Psoriatic Arthritis EU Clears BMS’s Sotyktu for Adults With Psoriatic Arthritis Read Post »
New Drug ApprovalInnovent Wins NMPA Approval for Multi-Dose Mazdutide Pen in Type 2 Diabetes Innovent Wins NMPA Approval for Multi-Dose Mazdutide Pen in Type 2 Diabetes Read Post »
